These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 26252441)

  • 41. Levetiracetam for manic behavior in hospitalized geriatric patients with dementia of the Alzheimer's type.
    Kyomen HH; Whitfield TH; Baldessarini RJ
    J Clin Psychopharmacol; 2007 Aug; 27(4):408-10. PubMed ID: 17632234
    [No Abstract]   [Full Text] [Related]  

  • 42. [The treatment with antihypertensive and nootropic preparations of hypertension patients working under neuroemotional stress].
    Dasaeva LA; Vertel' AE
    Ter Arkh; 1996; 68(12):60-3. PubMed ID: 9054044
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In reference to Usery JB et al. (J Neuro-oncol. 2010 Feb 10).
    Maschio M; Dinapoli L; Jandolo B
    J Neurooncol; 2010 Dec; 100(3):491-2. PubMed ID: 20461444
    [No Abstract]   [Full Text] [Related]  

  • 44. [Selection of neuromethabolic drug in severe brain injury].
    Zaĭtsev OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9):66-9. PubMed ID: 21246892
    [No Abstract]   [Full Text] [Related]  

  • 45. [The use of vinpotropile in chronic brain ishemia].
    Ivanova NE; Panuntsev VS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(1):73-5. PubMed ID: 18689011
    [No Abstract]   [Full Text] [Related]  

  • 46. [Use of fast-acting adaptogens and symptomatic means during evacuation of trauma victims by air transportation].
    Grechko AT; Glaznikov LA
    Aviakosm Ekolog Med; 1997; 31(2):47-9. PubMed ID: 9190256
    [No Abstract]   [Full Text] [Related]  

  • 47. Kinetic-dynamic monitoring of levetiracetam effects in patients with Parkinson disease and levodopa-induced dyskinesias.
    Contin M; Martinelli P; Albani F; Scaglione C; Avoni P; Rizzo G; Baruzzi A
    Clin Neuropharmacol; 2007; 30(2):122-4. PubMed ID: 17414945
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment and long-term follow-up of post-anoxic myoclonus].
    Janszky J; Holló A; Halász P
    Orv Hetil; 2001 Sep; 142(38):2091-3. PubMed ID: 11697066
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Idiopathic cortical myoclonia. A case report].
    Giroud JL; Hernandez R; Baez M; Fernandez A; Hernandez A; Paz L; Vistorte A
    Rev Neurol; 2000 Sep 16-30; 31(6):596-7. PubMed ID: 11055069
    [No Abstract]   [Full Text] [Related]  

  • 50. [State of the hemostasis system and pathogenetic therapy of circulatory encephalopathy].
    Bekuzarova MR; Burd GS; Kolesnikova TI; Iasamanova AN; Kabanov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(6):35-8. PubMed ID: 11517473
    [No Abstract]   [Full Text] [Related]  

  • 51. A casuistic rationale for the treatment of spastic and myocloni in a childhood neurodegenerative disease: neuronal ceroid lipofuscinosis of the type Jansky-Bielschowsky.
    Lorenz R
    Neuro Endocrinol Lett; 2002; 23(5-6):387-90. PubMed ID: 12500158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The treatment of mild cognitive disorders].
    Zakharov VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(12):121-5. PubMed ID: 24596976
    [No Abstract]   [Full Text] [Related]  

  • 53. Levetiracetam for the treatment of status epilepticus.
    Zheng F; Du C; Wang X
    Expert Rev Neurother; 2015 Oct; 15(10):1113-21. PubMed ID: 26416394
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Response to prophylactic treatment of benign headache in children].
    Garaizar C; Prats JM; Zuazo E
    Rev Neurol; 1998 Mar; 26(151):380-5. PubMed ID: 9585947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and nootropic activity of some 2,3-dihydro-1H-isoindol-1-one derivatives structurally related with piracetam.
    Reyes A; Huerta L; Alfaro M; Navarrete A
    Chem Biodivers; 2010 Nov; 7(11):2718-26. PubMed ID: 21072771
    [TBL] [Abstract][Full Text] [Related]  

  • 56. First preliminary results of an observation of Panax ginseng treatment in patients with autistic disorder.
    Niederhofer H
    J Diet Suppl; 2009; 6(4):342-6. PubMed ID: 22435515
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of botulinum neurotoxin A in uncontrolled salivation in children with cerebral palsy: a pilot study.
    Tiigimäe-Saar J; Leibur E; Kolk A; Talvik I; Tamme T
    Int J Oral Maxillofac Surg; 2012 Dec; 41(12):1540-5. PubMed ID: 23068112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The functional-morphological characteristics of alcohol-induced pathology as dependent on the nature of the intoxication and its nootropil correction in an experiment].
    Sidorov PI; Gromova LE; Solov'ev AG; Degteva GN; Leont'ev VIa; Savastenko AE
    Patol Fiziol Eksp Ter; 2000; (3):17-9. PubMed ID: 10983474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A neuroprotective effect of the herbal drug neurofit in alcoholic intoxication].
    Dashinamzhilov ZhB; Lonshakova KS; Ubasheev IO; Nikolaev SM; Gulevich AA
    Patol Fiziol Eksp Ter; 2007; (4):27-9. PubMed ID: 18154085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Levetiracetam in tardive dyskinesia: an open label study.
    Konitsiotis S; Pappa S; Mantas C; Mavreas V
    Mov Disord; 2006 Aug; 21(8):1219-21. PubMed ID: 16637037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.